DermConnect 2024 - Improving outcomes through real-world insights

About

DermConnect 2024 - Improving outcomes through real-world insights

Join our panel of international experts as they explore the latest advances and real-world challenges in the management of atopic dermatitis (AD) and alopecia areata (AA), featuring case-based discussions on personalised treatment strategies and how JAK inhibitors can optimise long-term outcomes in these patients.

CME points accreditation pending SMC approval for this event.

To report any adverse events related to Pfizer pharmaceutical products, please contact us via the following: [email protected]

If you have any medical enquiries about Pfizer pharmaceutical products, please contact our medical information services: [email protected] 

 

In collaboration:

Shangri-La Singapore
09

Nov

2024

12
:
30
PM
09

Nov

2024

05
:
00
PM

Speakers

Director of Allergy Centre, Singapore General Hospital
Chairperson and Moderator
A/Prof Lee Haur Yueh
Director of Allergy Centre Singapore General Hospital Singapore
Dermatologist, Southeast Dermatology Specialists
Global Expert
Dr George Hougeir
Dermatologist Southeast Dermatology Specialists United States
Head and Senior Consultant of Dermatology Service, KK Women’s and Children’s Hospital
Speaker & Panelist
A/Prof Mark Koh
Head and Senior Consultant of Dermatology Service KK Women’s and Children’s Hospital Singapore
Senior Consultant Department of Dermatology, Changi General Hospital
Speaker & Panelist
Dr Koh Wei Liang
Senior Consultant Department of Dermatology Changi General Hospital Singapore
Speaker & Panelist
Dr Angeline Yong
Dermatologist Angeline Yong Dermatology Gleneagles Medical Centre Singapore
PP-CIB-SGP-0191/27SEP2024